Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72,986 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recurrent GNAQ mutation encoding T96S in natural killer/T cell lymphoma.
Li Z, Zhang X, Xue W, Zhang Y, Li C, Song Y, Mei M, Lu L, Wang Y, Zhou Z, Jin M, Bian Y, Zhang L, Wang X, Li L, Li X, Fu X, Sun Z, Wu J, Nan F, Chang Y, Yan J, Yu H, Feng X, Wang G, Zhang D, Fu X, Zhang Y, Young KH, Li W, Zhang M. Li Z, et al. Among authors: wu j. Nat Commun. 2019 Sep 16;10(1):4209. doi: 10.1038/s41467-019-12032-9. Nat Commun. 2019. PMID: 31527657 Free PMC article.
Recurrent mutations in epigenetic modifiers and the PI3K/AKT/mTOR pathway in subcutaneous panniculitis-like T-cell lymphoma.
Li Z, Lu L, Zhou Z, Xue W, Wang Y, Jin M, Qiu Y, Sun W, Fu X, Zhang X, Chang Y, Nan F, Yan J, Wang G, Sun Z, Fu X, Li L, Li X, Wang X, Wu J, Zhang L, Zhang M. Li Z, et al. Among authors: wu j. Br J Haematol. 2018 May;181(3):406-410. doi: 10.1111/bjh.14611. Epub 2017 Mar 14. Br J Haematol. 2018. PMID: 28294301 Free article. No abstract available.
The efficacy and safety of gemcitabine, cisplatin, prednisone, thalidomide versus CHOP in patients with newly diagnosed peripheral T-cell lymphoma with analysis of biomarkers.
Li L, Duan W, Zhang L, Li X, Fu X, Wang X, Wu J, Sun Z, Zhang X, Chang Y, Nan F, Yan J, Li Z, Young KH, Zhang M. Li L, et al. Among authors: wu j. Br J Haematol. 2017 Sep;178(5):772-780. doi: 10.1111/bjh.14763. Epub 2017 Jun 9. Br J Haematol. 2017. PMID: 28597542 Free article. Clinical Trial.
Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma.
Li X, Cheng Y, Zhang M, Yan J, Li L, Fu X, Zhang X, Chang Y, Sun Z, Yu H, Zhang L, Wang X, Wu J, Li Z, Nan F, Tian L, Li W, Young KH. Li X, et al. Among authors: wu j. J Hematol Oncol. 2018 Jan 31;11(1):15. doi: 10.1186/s13045-018-0559-7. J Hematol Oncol. 2018. PMID: 29386072 Free PMC article.
An open label, single-armed, exploratory study of apatinib (a novel VEGFR-2 tyrosine kinase inhibitor) in patients with relapsed or refractory non-Hodgkin lymphoma.
Li L, Xiao S, Zhang L, Li X, Fu X, Wang X, Wu J, Sun Z, Zhang X, Chang Y, Nan F, Yan J, Li Z, Shi M, Young KH, Zhang M. Li L, et al. Among authors: wu j. Oncotarget. 2018 Jan 2;9(22):16213-16219. doi: 10.18632/oncotarget.23806. eCollection 2018 Mar 23. Oncotarget. 2018. PMID: 29662638 Free PMC article.
72,986 results
You have reached the last available page of results. Please see the User Guide for more information.